Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

  • Read more about Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

Bolt CSP-M Holter Study

  • Read more about Bolt CSP-M Holter Study

Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

  • Read more about Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

Bioatla, Inc

By jpalfreyman on Mon, 08/05/2024 - 16:08
  • Read more about Bioatla, Inc

Achieve Life Sciences

By jpalfreyman on Mon, 08/05/2024 - 09:45
  • Read more about Achieve Life Sciences

Attralus, Inc.

By jpalfreyman on Mon, 08/05/2024 - 09:37
  • Read more about Attralus, Inc.

Telerehabilitation of Balance Clinical and Economic Decision Support System

  • Read more about Telerehabilitation of Balance Clinical and Economic Decision Support System

The Relationship Between Belief, Expectation, and Adherence to Therapy During COVID-19 Pandemic

  • Read more about The Relationship Between Belief, Expectation, and Adherence to Therapy During COVID-19 Pandemic

Intermediate Expanded Access Protocol CNMAu8.EAP04

  • Read more about Intermediate Expanded Access Protocol CNMAu8.EAP04

Covid-19 Long Immunité IMagerie (CLIIM)

  • Read more about Covid-19 Long Immunité IMagerie (CLIIM)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Current page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA